Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
8/4/26 Otsuka Holdings (4578) Voyxact for Immunoglobulin A (IgA) Nephropathy (Berger's Disease) Subscribers Only Subscribers Only Subscribers Only
8/3/26 Rocket (RCKT) RP-A501 for Danon Disease Subscribers Only Subscribers Only Subscribers Only
8/3/26 Omeros (OMER) Yartemlea for Transplant-Associated Thrombotic Microangiopathy (TA-TMA) Subscribers Only Subscribers Only Subscribers Only
7/30/26 Crinetics (CRNX) Palsonify for Acromegaly Subscribers Only Subscribers Only Subscribers Only
7/30/26 CEL-SCI (CVM) Multikine for Head and Neck Cancer Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/26/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/08/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/17/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update